Introducing Nymphaea

A notable proportion of term and preterm infants develop neonatal jaundice. Jaundice in an otherwise healthy term infant is the most common reason for readmission to hospital. Jaundice is caused by an increase in serum bilirubin levels, largely as a result of breakdown of red blood cells. The liver converts bilirubin into a conjugated form which is excreted in the bile. Very high levels of unconjugated bilirubin are neurotoxic. Phototherapy is a simple and effective way to reduce the bilirubin level.

Nymphaea - Introducing Nymphaea

Depending on the severity of jaundice, phototherapy is administered from a single side or from both the sides to the baby. Overhead phototherapy units mounted on a stand are generally used to administer phototherapy from a single side.

Double surface phototherapy units currently available in the market are fixed to a warmer or bassinet. They do not provide us the leverage of swapping it to another equipment. Babies need to be shifted to an equipment dedicated to double surface phototherapy. We have designed a compact blue LED phototherapy which can be used in conjunction with any warmer, bassinet and incubator. Thus providing the staff the ease of providing phototherapy to a baby without having to shift it to a particular warmer or bassinet.

Nymphaea is sleek and light weight (<4Kg) and can be handled effortlessly by staff. The unit is flexible and harmonizes into the neonatal work space. Phototherapy can be administered without hindrance to respiratory and warming therapies.  It offers effective treatment with an efficient surface area coverage. The unit is suitable for term and pre-term babies. Nymphaea can be easily stored in a drawer or cup board. The surface is smooth without grooves and easy to clean. Infection control is vital in a NICU considering which there is no fan in the unit. The power consumption is minimal at 15W reducing the operation cost of the equipment.

Nymphaea can be used with a water mattress or gel mattress.

For more details write to

Factory in AMTZ

AMTZ ALL in 1 1024x624 - Factory in AMTZIndia’s first government funded medical devices park, Andhra Pradesh Med Tech Zone (AMTZ) hosted the 4th WHO global forum on 13-15 December 2018. Located in Vishakapatnam, AMTZ is a hub for manufacturing low-cost medical devices in India and simplify end-to-end process for the manufacturers. AMTZ will cut down imports in the medical devices sector and aim on providing accessible and affordable medical equipment ‘Made in India’.Spread over 270 acres the medical park will widen the scope of employment in the medical devices sector.  It is equipped with state of the art centralised 3D design, prototyping, testing and warehousing facilities for the manufacturers.

WhatsApp Image 2018 12 14 at 9.37.12 AM 2 1 768x1024 - Factory in AMTZHonourable Chief Minister of Andhra Pradesh, Shri.Chandrababu Naidu inaugurated our factory in AMTZ during the 4th WHO global forum. 
VVR 4137 1024x683 - Factory in AMTZ

VVR 4140 1024x683 - Factory in AMTZ

Former Opening Batsman for the Indian National Cricket Team, Mr.Virendar Sehwag also visited our factory in AMTZ during the WHO global forum .He has been appointed as the brand ambassador for AMTZ. It was an honour to have them inaugurate our factory in AMTZ.

Treat HIE with Brammi.

Neonatal Asphyxia occurs when infant doesn’t get oxygen. It can cause severe loss of oxygen to infant’s brain, which can injure brain cell causing HIE (Hypoxic Ischemic Encephalopathy).

The brain damage can cause mental and physical disabilities like cerebral palsy, seizure and developmental delays.

Brahmi HCM - Treat HIE with Brammi.

Every year, roughly 10 to 60% of babies with HIE die in the newborn period. At least 25% of babies with HIE with delayed treatment suffer neuro development. It is advised to treat babies within 6 hours from birth.

Start treatment at earliest with Brammi, a servo controlled cooling system. The treatment shows improved results by reducing the severity of brain injury. Brammi comes in 3 different modes for user usage. An infant body wrap designed for maximum coverage is provided for optimal cooling.

During servo controlled mode, the treatment lowers infant’s body temperature to 32˚ C for 72 hours decreasing the metabolic rate reducing further damage to brain cell due to oxygen deprivation or blood flow is restored to injured cells. The system maintains constant temperature with continuous feedback from infant. Post 72 hours, slow re-warming phase of 7 hours takes place.

Record complete treatment cycle with graphical representation for easy monitoring. Patient data can be extracted and saved through USB port.

Portable and light weight unit comes with integrated battery backup. This allows compatibility during transportation, allowing treatment to start with in 6 hours.

Smartcane in Gates Foundation Discovery Centre

Smartcane continues to bag laurels for its simple and efficient design. Having found its place at National Museums Scotland and Cooper Hewitt Smithsonian Design Museum, Smartcane has now entered the doors of Gates Foundation Discovery Center, in Seattle.

ssss - Smartcane in Gates Foundation Discovery Centre
The Gates Foundation Discovery Center is a catalyst to educate, inspire and motivate local and global awareness and action. Through exhibits and programmes, the Discovery Center convenes and connects people to relevant topics, stories and resources to inspire action. The cane will be displayed until 19 May 2019 at the ‘Design with the 90%’ exhibition in the Discovery Center. The exhibition highlights the role of design in addressing some of the world’s most critical problems.

Celebrating 60 years of Phototherapy

It is fairly common for newborn babies to have mild jaundice, and the condition is usually resolved without any intervention. Sometimes, however, the jaundice is severe, and if it is not treated, it leads to a condition called kernicterus. In this condition, the brain of the baby is damaged by the high level of bilirubin in the blood. This can result in problems with hearing and vision and in intellectual disabilities and cerebral palsy.

Fortunately, the treatment of this condition is simple. It requires exposing the skin of the baby to light, particularly blue light of a particular wavelength. This treatment is called phototherapy.

Phototherapy was discovered around 60 years back. Since then, this simple treatment has saved many babies from the ill effects of kernicterus.

An event was organized in Delhi on July 28 2018 at India Habitat Centre to celebrate six decades of phototherapy. It was aimed at spreading awareness about the serious effects of kernicterus, benefits of phototherapy and the health of newborn infants in general.

The Department of Pediatrics of AIIMS, PRESIDE (Pediatric Research and Education Society of India), IndiaNeoDesigns (a non-profit NGO of academia-industry promoting technology in neonatal health) and Stanford University, USA jointly organized a day-long event to commemorate 60-years of invention of phototherapy that has saved millions of babies. Phoenix Medical Systems was the industry partner for the event.

Indigenous innovations in the field of neonatology and maternal health were exhibited. It provided an opportunity for neonatal professionals, decision makers from private and government segment and technologists to discuss and collaborate.

India neodesign - Celebrating 60 years of Phototherapy

A panel discussion was held amidst stalwarts like Prof VK Bhutani, Prof ON Bhakoo , Prof JP Mittal ,    Prof Neelam Kler , Prof VK Paul etc.. Also a stakeholder meeting on India’s path to a global leader in  neonatal health technology involving NITI Ayog, ICMR, DBT, Wellcome Trust, BMGF, academia and industry was held.

India neodesign 01 - Celebrating 60 years of Phototherapy

A similar such event was organized in Chennai on Aug 1 2018. The event was jointly organized by the National Neonatology Forum (NNF) in partnership with IndiaNeodesigns. Among the guest speakers was Dr. Darez Ahmed, Mission Director of National Health Mission (NHM) and Dr. Arun Kumar Singh, National Advisor – RBSK.

SmartCane at National Museums Scotland

Blindness actually is a condition which brings in several limitations but these limitations actually can be brought down with the help of technology .You must have seen many visually impaired people use the white cane as a means to help them navigate and walk through their areas.However, this white cane is unable to detect any obstruction that is above the waist. For instance, an open window pane like this one will go undetected and most likely result in upper-body injury.
SmartCane is an interesting invention that uses ultrasonic waves to detect all such obstructions. This low cost device is already being used by thousands of people across the world
Smartcane 171x300 - SmartCane at National Museums Scotland
SmartCane has been  included in the National Museums Scotland exhibition on sight aides for a group of cases entitled ‘Engineering Humans’ .
The National Museums Scotland is the most visited attraction in the UK outside of London, drawing in over 1.7 million visitors a year. At National Museums Scotland, they care for collections of national and international importance, preserving them, interpreting them and making them accessible to as many people as possible. They highlight the importance of how manufacturing and engineering have changed our lives.  One of the galleries features a section on Technology by Design, where SmartCane has been exhibited.   SmartCane , a flagship product of Phoenix proudly standing in the National Museums Scotland brings in a sense of delight to the entire SmartCane team.


Phoenix partners with Windmill Health

Phoenix Medical always strives to be the first to bring pioneering technology to newborns. In this quest, Phoenix now partners with Windmill Health, to present NeoBreathe, the world’s first foot operated newborn resuscitation system.

NeoBreathe frees one hand of the user from bagging – allowing a two handed mask grip – which is known to improves face-mask sealing by over 50%.In addition,
it enables unprecedented multi-tasking– allowing auscultation without assistance, and single person CPR. It integrates foot powered suction, pressure monitoring, enhanced pressure safety, PEEP and FiO2 regulation – all in one robust solution.

NeoBreathe shows proven improvements in breathe delivery in studies. For details visit

NeoBreathe, an internationally awarded invention, was invented at Stanford-India Biodesign, AIIMS, New Delhi , Stanford University and IIT, Delhi faculty as co-inventors. It was further developed by Windmill Health, a company founded by its physican inventors from Stanford and AIIMS.

NeoBreathe is simplifying saving lives in hospitals across 14 states of India and most recently, it received a National Technology Award from the Hon’ble President of India on National Technology Day 2017.

Phoenix is proud to partner with Windmill Health to be the first to bring this pioneering product to newborns across the globe.

Patient Safety Pledge

Phoenix has signed the Patient Safety Movement Foundation’s Open Data Pledge and joined the elite group of 76 companies

that have come together to help eliminate preventable patient deaths by the year 2020. We were awarded to highlight the importance of this pledge and our commitment to patient safety.
At the Patient Safety Movement, we believe that ZERO preventable deaths by 2020 is not just a worthy goal. With the right people, ideas, and technology, it’s an attainable goal. Many of the pieces of this puzzle already exist. Solving this problem is a matter of connecting the dots of patient safety.

The Patient Safety Movement is working to connect these dots in a number of ways: by collaborating and breaking down information silos that exist between hospitals, medical technology companies, the government, and other stakeholders; by promoting the sharing of data that can identify at-risk patients before they’re in danger; and by providing specific,actionable solutions that healthcare professionals can implement today so we can reach our goal together.

Our Patient Safety Movement Mission is to share the data our devices generate in order to create a Patient Data Super Highway to help identify at-risk patient

Phoenix will be displaying the award the award at key conferences and events to raise awareness about the Patient Safety Movement.


2017 TIME India Award

On 27 January 2017, Time Inc. announced the winners of the Second Annual TIME India Awards, at the Confederation of Indian Industry (CII) Partnership Summit, in Andhra Pradesh, India.

The Indian Minister of Finance, Arun Jaitley, Minister of State for Commerce and Industry, Nirmala Sitharaman, and Andhra Pradesh Chief Minister, N. Chandrababu Naidu, presented the awards. McKinsey & Company was the knowledge partner for the awards.The 2017 TIME India Awards recognized the country’s most exciting startups and small and medium-sized businesses.

Phoenix Medical Systems was the winner of the MSME Innovator for the Year award, which was received by the Managing Director, V. Sashi Kumar, and Executive Director, Smita Sashikumar. The winners of the awards were selected among 18 finalists, who were identified from a pool of approximately 15,000 manufacturing companies after an assessment of their qualitative and quantitative parameters. The finalists were announced at the World Economic Forum at Davos, Switzerland, in January 2017.

A jury of key business magnates led by Vice Chairman of Time Inc., Norman Pearlstine, selected the winners of the Time India Awards in each category. The panel included General Electric Vice Chairman, John Rice; Infosys Founder, N.R. Narayana Murthy; ICICI Bank Managing Director and Chief Executive Officer, Chanda Kochhar; Time Inc. Executive Editor, International, Clay Chandler; and McKinsey & Company Chairman (Asia), Kevin Sneader.

The Festival of Innovation

The Festival of Innovation (FOIN) is a unique initiative to recognize creative solutions to challenges faced by the society.

It is hosted by the President of India at Rashtrapati Bhavan as a week-long event in March. This year it was organized by the President’s Secretariat, with assistance from the National Innovation Foundation (NIF) and Society for Research and Initiatives for Sustainable Technologies and Institutions (SRISTI).

For the second consecutive year a Phoenix innovation was honored by being selected for exhibition at FOIN. The selection was based on functionality, cost-effectiveness, acceptability and relevance to public health.

The members of the selection committee are renowned clinicians, engineering professionals from IITs, scientists, government officials from science departments and representatives of industry.

The selection was made from a pool of 450 brilliant innovations through an extremely meticulous process.

The special jury award was presented to the project titled ‘Neonatal Resuscitation Trolley with Delayed Cord Clamping’, being carried out in collaboration with the Department of Neonatalogy, Madras Medical College.